CMMBVSNRSN• 7 Days (Normalized)
CMMB vs NRSN (Chemomab Therapeutics Ltd. vs NeuroSense Therapeutics Ltd.)
Showing Closing Date Range from Sep 23 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CMMB Performance $1.67
-26.75%
Chemomab Therapeutics Ltd.
Normalized Baseline0.00%
NRSN Performance $4.78
-35.41%
NeuroSense Therapeutics Ltd.
Normalized Baseline0.00%
Alpha Spread Margin CMMB LEADS
+8.66 pts
CMMB outperforming by 8.66 percentage points
CMMBNRSN
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CMMB NRSN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | CMMB Price | CMMB Gain (%) | NRSN Price | NRSN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $1.67 | -26.75% | $4.78 | -35.41% | +8.66% |
| Sep 28, 2026 | $1.64 | -28.07% | $5.10 | -31.08% | +3.01% |
| Sep 25, 2026 | $2.16 | -5.26% | $6.95 | -6.08% | +0.82% |
| Sep 24, 2026 | $2.20 | -3.51% | $7.40 | +0.00% | -3.51% |
| Sep 23, 2026 | $2.28 | +0.00% | $7.40 | +0.00% | +0.00% |